Clemensson L: Difference between revisions
From Bioblast
Beno Marija (talk | contribs) No edit summary |
Beno Marija (talk | contribs) No edit summary Β |
||
| Line 10: | Line 10: | ||
|country=Sweden | |country=Sweden | ||
|mailaddress=laura.clemensson@neuro.uu.se | |mailaddress=laura.clemensson@neuro.uu.se | ||
|weblink=https://wiki.oroboros.at/index.php/FAT4BRAIN | |||
}} | }} | ||
{{Labelingperson}} | {{Labelingperson}} | ||
Latest revision as of 11:17, 3 March 2022
| Name | Clemensson Laura, |
|---|---|
| Institution | University of Uppsala, Department of Neuroscience  Functional Pharmacology |
| Address | BMC, Box 593,, 751 24 |
| City | Uppsala |
| State/Province | |
| Country | Sweden |
| laura.clemensson@neuro.uu.se | |
| Weblink | https://wiki.oroboros.at/index.php/FAT4BRAIN |
| O2k-Network Lab |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Liepinsh 2024 Br J Pharmacol | 2024 | Liepinsh E, Zvejniece L, Clemensson L, Ozola M, Vavers E, Cirule H, Korzh S, Skuja S, Groma V, Briviba M, Grinberga S, Liu W, Olszewski P, Gentreau M, Fredriksson R, Dambrova M, SchiΓΆth HB (2024) Hydroxymethylglutaryl-CoA reductase activity is essential for mitochondrial Ξ²-oxidation of fatty acids to prevent lethal accumulation of long-chain acylcarnitines in the mouse liver. Br J Pharmacol [Epub ahead of print]. https://doi.org/10.1111/bph.16363 |
Abstracts
| Published | Reference | |
|---|---|---|
| Clemensson 2018 MiP2018 | 2018 | |
